Free Massachusetts PTCB Practice Test Online

Correct answer: A. A pharmacy technician trainee may work for no more than 1500 hours or one year, whichever is shorter

Correct. M.G.L. c. 112, § 24F specifies that a pharmacy technician trainee may not work for more than 1500 hours or one year, whichever period is shorter.

• B: The 2000-hour requirement is not part of Massachusetts trainee regulations.
• C: Massachusetts law establishes specific limits on trainee practice duration.
• D: The limit is one year, not two years; this is specified in state regulations.

Correct answer: A. Receiving telephone prescriptions from patients or prescribers

Correct. 247 CMR 8.03 specifies that a pharmacy technician trainee may not take prescriptions over the telephone.

• B: Data entry is an appropriate clerical task for trainees under supervision.
• C: Pulling medications from inventory is an appropriate technician task when done under supervision.
• D: Counting and organizing medications is an appropriate trainee task under pharmacist supervision.

Correct answer: A. The major risks must be presented as prominently as benefits

Correct. FDA regulations require that major risks and benefits be presented with relatively equal prominence in direct-to-consumer advertising.

• B: All significant risks, not just mild ones, must be disclosed in drug advertising.
• C: Risks do not need to equal benefits in prominence, but major risks must be clearly stated.
• D: Risk information cannot be minimized due to space constraints; full disclosure is required.

Correct answer: A. 21 CFR 312.3, which establishes Investigational New Drug Application procedures

Correct. 21 CFR 312.3 specifically establishes the procedures for Investigational New Drug (IND) Applications required before an experimental drug can be used in clinical trials, including dispensing requirements.

• B: 21 CFR 320.1 addresses bioavailability and bioequivalence standards for drug absorption, not clinical trial dispensing.
• C: 21 CFR 201.56 governs patient package inserts and consumer labeling, not investigational drug protocols.
• D: 21 CFR 110.1 covers Current Good Manufacturing Practice (cGMP) regulations for facilities and equipment, not investigational drug protocols.

Correct answer: B. Flag the prescription for pharmacist review due to potential overdose risk

Correct. A pharmacy technician must flag potential safety issues for pharmacist review without making independent clinical decisions.

• A: Dispensing without review creates patient safety risk; 4 tablets every 4 hours = 8000 mg/day, exceeding safe limits.
• C: Technicians cannot contact prescribers about clinical changes; this is a pharmacist responsibility per scope of practice.
• D: Substituting products without authorization violates scope of practice and professional standards.